These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26473923)

  • 1. Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development.
    Schmohl JU; Todhunter D; Oh S; Vallera DA
    Toxins (Basel); 2015 Oct; 7(10):4067-82. PubMed ID: 26473923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DT390-triTMTP1, a novel fusion protein of diphtheria toxin with tandem repeat TMTP1 peptide, preferentially targets metastatic tumors.
    Ma X; Lv P; Ye S; Zhang Y; Li S; Kan C; Fan L; Liu R; Luo D; Wang A; Yang W; Yang S; Bai X; Lu Y; Ma D; Xi L; Wang S
    Mol Pharm; 2013 Jan; 10(1):115-26. PubMed ID: 23198829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Deimmunized Bispecific Immunotoxin dDT2219 against B-Cell Malignancies.
    Schmohl JU; Todhunter D; Taras E; Bachanova V; Vallera DA
    Toxins (Basel); 2018 Jan; 10(1):. PubMed ID: 29316610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
    Hall WA; Vallera DA
    Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
    Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
    Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and characterisation of A and B fragments of Corynebacterium diphtheriae toxin towards recombinant diphtheria vaccine.
    Abulmagd S; Emara M; Aziz S; El-Domany R
    Indian J Med Microbiol; 2013; 31(1):3-9. PubMed ID: 23508421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphtheria toxin-based recombinant murine IL-2 fusion toxin for depleting murine regulatory T cells in vivo.
    Wei M; Marino J; Trowell A; Zhang H; Stromp Peraino J; Rajasekera PV; Madsen JC; Sachs DH; Huang CA; Benichou G; Wang Z
    Protein Eng Des Sel; 2014 Sep; 27(9):289-95. PubMed ID: 25147093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier potential properties of Bacillus thuringiensis Cry1A toxins for a diphtheria toxin epitope.
    Guerrero GG; Moreno-Fierros L
    Scand J Immunol; 2007 Dec; 66(6):610-8. PubMed ID: 17949406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity.
    Kageyama T; Ohishi M; Miyamoto S; Mizushima H; Iwamoto R; Mekada E
    J Biochem; 2007 Jul; 142(1):95-104. PubMed ID: 17525101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a diphtheria toxin-based recombinant porcine IL-2 fusion toxin for depleting porcine CD25+ cells.
    Peraino JS; Schenk M; Li G; Zhang H; Farkash EA; Sachs DH; Huang CA; Duran-Struuck R; Wang Z
    J Immunol Methods; 2013 Dec; 398-399():33-43. PubMed ID: 24055128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The research on construction and expression of eukaryotic expression plasmid for a recombinant immunotoxin mMIP-1alpha-DT390].
    Lü ML; Li H; Liang WB; Chen WJ; Jia Y; Jiang ZH; Zhang WD; Zhang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):1-5. PubMed ID: 17294715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of CD8+ T cells following diphtheria toxin-mediated antigen delivery into dendritic cells.
    Shaw CA; Starnbach MN
    Infect Immun; 2006 Feb; 74(2):1001-8. PubMed ID: 16428746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
    Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
    Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A truncated diphtheria toxin based recombinant porcine CTLA-4 fusion toxin.
    Peraino JS; Schenk M; Zhang H; Li G; Hermanrud CE; Neville DM; Sachs DH; Huang CA; Duran-Struuck R; Wang Z
    J Immunol Methods; 2013 May; 391(1-2):103-11. PubMed ID: 23470981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood.
    Thompson J; Hu H; Scharff J; Neville DM
    J Biol Chem; 1995 Nov; 270(47):28037-41. PubMed ID: 7499288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting glioblastoma multiforme with an IL-13/diphtheria toxin fusion protein in vitro and in vivo in nude mice.
    Li C; Hall WA; Jin N; Todhunter DA; Panoskaltsis-Mortari A; Vallera DA
    Protein Eng; 2002 May; 15(5):419-27. PubMed ID: 12034862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and immunogenicity of a recombinant diphtheria toxin fragment A in Streptococcus gordonii.
    Lee CW; Lee SF; Halperin SA
    Appl Environ Microbiol; 2004 Aug; 70(8):4569-74. PubMed ID: 15294787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
    Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
    Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mice expressing a fully nontoxic diphtheria toxin mutant, not CRM197 mutant, acquire immune tolerance against diphtheria toxin.
    Kimura Y; Saito M; Kimata Y; Kohno K
    J Biochem; 2007 Jul; 142(1):105-12. PubMed ID: 17522091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphtheria toxin-interleukin-3 fusion protein (DT(388)IL3) prolongs disease-free survival of leukemic immunocompromised mice.
    Black JH; McCubrey JA; Willingham MC; Ramage J; Hogge DE; Frankel AE
    Leukemia; 2003 Jan; 17(1):155-9. PubMed ID: 12529673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.